Matches in SemOpenAlex for { <https://semopenalex.org/work/W119842590> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W119842590 endingPage "74" @default.
- W119842590 startingPage "3967" @default.
- W119842590 abstract "Incidental prostate cancer (PCa) has been demonstrated at autopsy in about 80% of men aged 80 years and above and also in 10%-15% of younger men aged 30-50 years in the United States. These data imply a wide variation in aggressiveness of prostate cancer, from indolent tumors to aggressive cancers that kill the patients. The use of prostate specific antigen (PSA) in screening for PCa may detect even indolent disease for which radical prostatectomy may not be necessary. Currently available criteria such as histological grade, PSA level, stage of the disease do not always predict outcome. Furthermore, only about 80% of men with metastatic PCa will respond to first line hormone manipulation and once the patient develops hormone resistant prostate cancer (HRPCa), survival remains poor. Recent genomic and proteomic studies have provided many novel molecular markers that may help to redefine prognostic parameters. This paper is a review of studies using these novel markers in order to determine whether prostate cancer patients with the following characteristics have more aggressive cancer than those without: a) high serum levels of cathepsin B, survivin, Her - 2 / neu, IGFBP-2; b) low serum stefin A, IGFBP-3, c) positive immuno-staining of primary tumors for Her-2/neu, survivin and cathepsin B / stefin A ratio > 1 and d) gene expression of AMACR, HER-2/neu, high Bcl-2: Bax ratio and EZH2 in cancer cells. These markers have been chosen for review because they are among the most promising markers emerging currently." @default.
- W119842590 created "2016-06-24" @default.
- W119842590 creator A5018206352 @default.
- W119842590 creator A5027758544 @default.
- W119842590 creator A5089849344 @default.
- W119842590 date "2008-04-01" @default.
- W119842590 modified "2023-09-27" @default.
- W119842590 title "The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers." @default.
- W119842590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18405443" @default.
- W119842590 hasPublicationYear "2008" @default.
- W119842590 type Work @default.
- W119842590 sameAs 119842590 @default.
- W119842590 citedByCount "8" @default.
- W119842590 countsByYear W1198425902012 @default.
- W119842590 countsByYear W1198425902015 @default.
- W119842590 countsByYear W1198425902022 @default.
- W119842590 crossrefType "journal-article" @default.
- W119842590 hasAuthorship W119842590A5018206352 @default.
- W119842590 hasAuthorship W119842590A5027758544 @default.
- W119842590 hasAuthorship W119842590A5089849344 @default.
- W119842590 hasConcept C121608353 @default.
- W119842590 hasConcept C126322002 @default.
- W119842590 hasConcept C142724271 @default.
- W119842590 hasConcept C143998085 @default.
- W119842590 hasConcept C173633252 @default.
- W119842590 hasConcept C181199279 @default.
- W119842590 hasConcept C2775975398 @default.
- W119842590 hasConcept C2776235491 @default.
- W119842590 hasConcept C2779134260 @default.
- W119842590 hasConcept C2779466945 @default.
- W119842590 hasConcept C2780192828 @default.
- W119842590 hasConcept C2781406297 @default.
- W119842590 hasConcept C55493867 @default.
- W119842590 hasConcept C71924100 @default.
- W119842590 hasConcept C86803240 @default.
- W119842590 hasConceptScore W119842590C121608353 @default.
- W119842590 hasConceptScore W119842590C126322002 @default.
- W119842590 hasConceptScore W119842590C142724271 @default.
- W119842590 hasConceptScore W119842590C143998085 @default.
- W119842590 hasConceptScore W119842590C173633252 @default.
- W119842590 hasConceptScore W119842590C181199279 @default.
- W119842590 hasConceptScore W119842590C2775975398 @default.
- W119842590 hasConceptScore W119842590C2776235491 @default.
- W119842590 hasConceptScore W119842590C2779134260 @default.
- W119842590 hasConceptScore W119842590C2779466945 @default.
- W119842590 hasConceptScore W119842590C2780192828 @default.
- W119842590 hasConceptScore W119842590C2781406297 @default.
- W119842590 hasConceptScore W119842590C55493867 @default.
- W119842590 hasConceptScore W119842590C71924100 @default.
- W119842590 hasConceptScore W119842590C86803240 @default.
- W119842590 hasIssue "2" @default.
- W119842590 hasLocation W1198425901 @default.
- W119842590 hasOpenAccess W119842590 @default.
- W119842590 hasPrimaryLocation W1198425901 @default.
- W119842590 hasRelatedWork W1852076013 @default.
- W119842590 hasRelatedWork W1968445925 @default.
- W119842590 hasRelatedWork W1983182856 @default.
- W119842590 hasRelatedWork W2003596450 @default.
- W119842590 hasRelatedWork W2022572692 @default.
- W119842590 hasRelatedWork W2024291911 @default.
- W119842590 hasRelatedWork W2025284670 @default.
- W119842590 hasRelatedWork W2083393874 @default.
- W119842590 hasRelatedWork W2110872866 @default.
- W119842590 hasRelatedWork W2133720955 @default.
- W119842590 hasRelatedWork W2145115817 @default.
- W119842590 hasRelatedWork W2156094924 @default.
- W119842590 hasRelatedWork W2207669299 @default.
- W119842590 hasRelatedWork W2567249750 @default.
- W119842590 hasRelatedWork W2587810607 @default.
- W119842590 hasRelatedWork W2755675304 @default.
- W119842590 hasRelatedWork W2782421307 @default.
- W119842590 hasRelatedWork W2921050568 @default.
- W119842590 hasRelatedWork W2992423560 @default.
- W119842590 hasRelatedWork W3089982446 @default.
- W119842590 hasVolume "15" @default.
- W119842590 isParatext "false" @default.
- W119842590 isRetracted "false" @default.
- W119842590 magId "119842590" @default.
- W119842590 workType "article" @default.